TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/14/25 17:49 | 2/13/25 | CMRX | Chimerix Inc | DE | Health | Drug | Pharmaceutical Preparations | Andriole Michael T. | NC | DO | P,CEO | S | -33 | 4.52 | 0 | -7 | -1 | 610 | D | ||||||||||||||
1/31/25 16:38 | 1/30/25 | CMRX | Chimerix Inc | DE | Health | Drug | Pharmaceutical Preparations | Andriole Michael T. | NC | DO | P,CEO | S | -10 | 4.10 | 0 | -2 | 0 | 617 | D | ||||||||||||||
8/9/24 12:01 | 8/8/24 | CMRX | Chimerix Inc | DE | Health | Drug | Pharmaceutical Preparations | Andriole Michael T. | NC | DO | P,CEO | S | -1 | 0.8285 | 0 | -1 | 0 | 462 | D | ||||||||||||||
2/16/24 20:02 | 2/14/24 | CMRX | Chimerix Inc | DE | Health | Drug | Pharmaceutical Preparations | Andriole Michael T. | NC | DO | P,CEO | S | -2 | 1.04 | 0 | -2 | 0 | 447 | D | ||||||||||||||
10/9/18 14:16 | 10/5/18 | ECYT | Endocyte Inc | DE | Health | Drug | Pharmaceutical Preparations | Andriole Michael T. | IN | O | CFO | S.m | -279 | 15.56 | 0 | -18 | -12 | 132 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |